Related Experiment Video
Updated: Nov 2, 2025

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
Joanna Kamińska1, Marek Stopiński1, Krzysztof Mucha2,3
1Department of Internal Diseases and Dialysis Unit, West Hospital of Saint John Paul II, Grodzisk Mazowiecki, Poland.
Insights
Osteoprotegerin (OPG) levels predict mortality in chronic kidney disease (CKD) patients. Measuring OPG, potentially with coronary calcium score, can help stratify mortality risk in CKD stages 3-4 and end-stage renal disease.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Chronic kidney disease (CKD) is linked to cardiovascular disease, mineral and bone disorder, and increased mortality.
- Bone-related factors like osteopontin (OPN), osteocalcin (OC), osteoprotegerin (OPG), and fibroblast growth factor 23 (FGF23) are implicated in CKD's cardiovascular complications.
- These factors may hold predictive value for mortality in CKD patients.
Purpose of the Study:
- To investigate the relationship between OPN, OC, OPG, and FGF23 with clinical characteristics in CKD patients.
- To assess the predictive ability of these bone-related factors for mortality across different stages of CKD.
Main Methods:
- Study groups included end-stage renal disease (ESRD) (38), CKD stages 3-4 (19), and non-CKD controls (19).
- Serum concentrations of OPN, OC, OPG, and FGF23 were measured from a single blood draw.
- Coronary calcium score (CS) was evaluated using cardiac computed tomography, and patients were followed for 5-year all-cause mortality.
Main Results:
- Serum OPN, OC, and OPG levels significantly increased with CKD progression and were positively correlated.
- OPN and OPG showed significant positive correlations with coronary calcium score.
- Serum OPG demonstrated the strongest association with declining GFR and predicted increased mortality risk in CKD3-4 and ESRD patients (HR 5.8).
Conclusions:
- A single measurement of osteoprotegerin is associated with 5-year all-cause mortality in patients with CKD stages 3-4 or ESRD.
- Assessing OPG concentration, ideally combined with coronary calcium score, is suggested for stratifying mortality risk in CKD patients.
Background:
Chronic kidney disease (CKD) is associated with cardiovascular disease (CKD), mineral and bone disorder (CKD-MBD) and high mortality. Bone-related factors such as osteopontin (OPN), osteocalcin (OC), osteoprotegerin (OPG) and fibroblast growth factor 23 (FGF23) were linked to cardiovascular complications of CKD and are expected to have predictive value in CKD patients.
Purpose:
The aim of this study was to assess the relationship of OPN, OC, OPG and FGF23 to clinical characteristics and to evaluate their ability to predict mortality in patients with different CKD stages.
Methods:
The following study groups were enrolled: subjects with end-stage renal disease (38 ESRD), CKD stages 3 and 4 (19 CKD3-4) and non-CKD controls (19), respectively. Blood was withdrawn once to perform the measurements and cardiac computed tomography was used to evaluate coronary calcium score (CS). Patients were followed for 5 years for the ascertainment of their all-cause mortality.
Results:
Serum OPN, OC and OPG concentrations increased significantly along with the progression of renal disease. We found a significant positive correlation among these proteins. Additionally, OPN and OPG were significantly and positively correlated to CS. Serum OPG revealed the strongest correlation to the calcium turnover markers of GFR decline and was significantly associated with an increased risk of death in subjects with CKD3-4 or ESRD (HR 5.8, CI 95%).
Conclusion:
Single measurement of osteoprotegerin is associated with 5-year all-cause mortality in patients with CKD3-4 or ESRD. We suggest assessing its concentration, preferably in combination with calcium score, to stratify mortality risks in CKD patients.
More Related Videos
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Osteoclasts in Bone Remodeling
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Bone Remodeling
Acute Kidney Injury II: Pathophysiology